心力衰竭患者流感疫苗接种与常规实践比较:基于模型的成本效果分析
该研究在中国河南省县级医院心内科构建假设性出院心力衰竭患者队列,采用四健康状态马尔可夫模型,从卫生系统视角、以一年时间跨度,比较出院当日免费接种流感疫苗(含医生推荐和院内接种点)与常规护理(出院时建议前往社区接种点)的成本效果。在每QALY 37668美元支付意愿阈值下,干预策略具有成本效果的概率为84%。
要点
- 出院当日免费接种流感疫苗相比常规护理人均年节省443美元,QALY增加0.03。
- 每1000名出院患者实施干预可减少28例流感样疾病、164例再住院、44例死亡。
- 在每QALY 37668美元阈值下,干预具有成本效果的概率为84%。
核心结论
- 尽管极少数心内科病房常规为出院患者提供流感疫苗接种,但这样做有可能挽救生命并减少政府医疗支出。
研究设计与样本
- 研究为成本效果分析,采用四健康状态马尔可夫模型,构建中国河南省县级医院心内科出院存活心力衰竭患者的假设性队列。
- 干预为出院当日免费提供流感疫苗、由主治医生推荐并在院内便利接种点接种,对照为常规护理(出院时一般建议前往社区接种点)。
- 分析从卫生系统视角开展,时间跨度为一年,结局包括成本、流感样疾病、再住院、死亡和QALY。
主要发现
- 干预策略人均年成本为2456美元,常规护理为2899美元,干预策略人均年节省443美元。
- 干预策略人均年获得0.57个QALY,常规护理为0.53个QALY,干预策略QALY高0.03。
- 单因素敏感性分析中,干预策略在广泛假设范围内保持稳健的成本效果。
- 在每QALY 37668美元支付意愿阈值下,干预策略具有成本效果的概率为84%。
临床怎么用
- 原文结论指出,尽管极少数心内科病房常规为出院患者提供流感疫苗接种,但这样做有可能挽救生命并减少政府医疗支出。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: People with heart failure (HF) are at higher risk of experiencing severe cardiac complications including hospitalization and death, from seasonal influenza infection. In addition to preventing influenza infections, influenza vaccination's effect on preventing hospitalization and death may impact its cost-effectiveness among people with HF. Moreover, uncertainty of its cost-effectiveness has been reported as a barrier for public funding of influenza vaccination in such populations. METHODS: We conducted a cost-effectiveness analysis of a program of seasonal influenza vaccination for patients with HF upon discharge from hospital, compared to usual care, in China. The analysis involved four-health-state Markov model in which we modelled a hypothetical cohort of patients discharged alive with HF from county-level hospital cardiology wards in Henan Province, China. The intervention is provision of free influenza vaccine on the day of hospital discharge, with treating physician's recommendation, and convenient Point of Vaccination (PoV) within the hospital. The comparator is usual care, which generally would be advice at discharge to attend a community based PoV. We performed a cost-effectiveness analysis from a health system perspective with a one-year time horizon. Outcomes were cost, influenza-like-illness (ILI), readmission, death, and quality-adjusted life year (QALY). FINDINGS: The intervention strategy had an overall cost of US$ 2,456 per person per year compared to the cost of $2,899 per person per year with usual care. The intervention strategy resulted in 0.57 QALYs per person per year, compared to 0.53 QALYs under usual care. The intervention strategy was dominant over usual care - with estimated cost savings of $443 and 0.03 higher QALYs per patient discharged alive over 12 months. Overall, implementing the influenza vaccination strategy in a cohort of 1,000 individuals results in 28 less ILI cases, 164 fewer hospitalizations, and 44 fewer deaths per 1,000 patients discharged alive, and overall cost savings of $443,000 over this period. In one-way sensitivity analysis, the intervention strategy remains robustly cost-effective across a wide range of assumptions. The probability of intervention strategy being cost-effective is 84 %, at the willingness-to-pay threshold of $37,668 per QALY. CONCLUSION: Although very few hospital wards routinely offer influenza vaccination for patients on discharge, doing so has the potential to both save lives and reduce government health care expenditure. TRIAL REGISTRATION: ChiCTR.org.cn: ChiCTR2000039081.
引用
- Liu R, Patel A, Liu H, et al. Influenza vaccination in patients with heart failure compared to usual practice: A model-based cost-effectiveness analysis. Vaccine. 2025. PMID: 40753672. doi:10.1016/j.vaccine.2025.127566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。